Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Gastroenterology | Radiology | Conference News

Back to Journal Articles

RSNA: Left Gastric Artery Embolization Ups Weight Loss

Last Updated: November 26, 2013.

 

Findings among patients with upper GI bleeding undergoing transarterial embolization

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Left gastric artery embolization improves weight loss among patients with upper gastrointestinal bleeding treated with transarterial embolization, according to a study presented in advance of the annual meeting of the Radiological Society of North America, held from Dec. 1 to 6 in Chicago.

TUESDAY, Nov. 26, 2013 (HealthDay News) -- Left gastric artery embolization improves weight loss among patients with upper gastrointestinal bleeding treated with transarterial embolization, according to a study presented in advance of the annual meeting of the Radiological Society of North America, held from Dec. 1 to 6 in Chicago.

Rahmi Oklu, M.D., Ph.D., from Harvard Medical School in Boston, and colleagues conducted a retrospective analysis of electronic medical records to examine post-procedural weight loss in patients after left gastric artery embolization for upper gastrointestinal bleeding. The analysis included 15 patients in an experimental group (mean age, 66.1 years) and 18 age-matched controls (mean age, 63.5 years) who had undergone embolization of an artery other than the left gastric artery for upper gastrointestinal bleeding.

The researchers found that in the experimental group there was a 7.9 percent decrease in body weight post-procedure (from 189.1 lbs to 174.5 lbs). In the control group there was a 1.2 percent decrease in body weight (from 164.7 lbs to 162.8 lbs). Post-procedural weight loss was significantly greater in the experimental versus the control group (P = 0.001).

"Embolizing the left gastric artery may be a potential bariatric treatment for weight loss and an alternative to other invasive procedures," Oklu said in a statement. "This is an important data point in the development of a new clinical tool for the treatment of obesity."

Press Release
More Information

Copyright © 2013 HealthDay. All rights reserved.


Previous: Chest Pain Characteristics Don't Help Diagnose AMI in Women Next: FDA Approves Olysio As Hepatitis C Treatment

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.